Do noradrenergic alterations in Parkinson’s disease indicate a therapeutic target? A combined PET & neuromelanin MRI study
The Brain Podcast - A podcast by Joanne Bell - Wednesdays
![](https://is1-ssl.mzstatic.com/image/thumb/Podcasts122/v4/a2/50/47/a25047ea-5205-e021-ea24-dd86687f64ee/mza_12603103393080874903.jpg/300x300bb-75.jpg)
Welcome to the 17th episode of The Brain Podcast - the official podcast of the journals Brain and Brain Communications. This episode features a discussion with senior author Dr Bénédicte Ballanger of the Brain article entitled: Noradrenergic alterations in Parkinson’s disease: a combined 11C-yohimbine PET/neuromelanin MRI study Can this multi-modal study examining the role of Noradrenaline in Parkinson's disease offer insight into important neurotrasmitter pathophysiology and provide the basis for a non-dopamine therapeutic strategy? Check out the full article on the Brain website: https://doi.org/10.1093/brain/awad338 This episode was co-hosted by Andreas Themistocleous and Michael David, edited and produced by Michael David and Xin You Tai, co-produced by Antonia Johnston, original music by Ammar Al-Chalabi.